Details for New Drug Application (NDA): 203335
✉ Email this page to a colleague
The generic ingredient in BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE is aspirin; butalbital; caffeine; codeine phosphate. There are twenty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the aspirin; butalbital; caffeine; codeine phosphate profile page.
Summary for 203335
Tradename: | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE |
Applicant: | Dr Reddys Labs Sa |
Ingredient: | aspirin; butalbital; caffeine; codeine phosphate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 325MG;50MG;40MG;30MG | ||||
Approval Date: | Oct 30, 2015 | TE: | RLD: | No |
Complete Access Available with Subscription